<DOC>
	<DOC>NCT02612675</DOC>
	<brief_summary>This will be a randomized, cross-over study of two oral nutrition supplements in individuals with Type 2 Diabetes.</brief_summary>
	<brief_title>Glycemic Response to Oral Nutrition Supplements</brief_title>
	<detailed_description />
	<criteria>Age 2075 yrs Type 2 diabetes controlled with diet or diet and oral agent, with the exception of sulfonylureas such as glimepiride (Amaryl), glipizide (Glucotrol/Glucotrol XL) and glyburide (DiaBeta, Micronase, Glynase Prestabs); meglitinides such as reaglinide (Prandin) and nateglinide (Starlix); and alphaglucosidase inhibitors such as acarbose (Precose) and miglitol (Glyset) Hemoglobin A1C less than 9.0% Fasting blood glucose less than 180 mg Allergy to milk protein or any other component of the formula</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>